Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 6.08 Billion | USD 12.36 Billion | 8.2% | 2023 |
The intravenous access devices market size was worth around USD 6.08 Billion in 2023 and is predicted to grow to around USD 12.36 Billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.2% between 2024 and 2032.
The report covers a forecast and an analysis of the intravenous access devices market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million). The study includes the drivers and restraints of the intravenous access devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the intravenous access devices market on a global and regional level.
In order to give the users of this report a comprehensive view of the intravenous access devices market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
Intravenous access devices are a part of vascular access devices, which play a crucial role in the healthcare sector. These devices are inserted into a person’s veins through peripheral vessels for treating diagnostic conditions. Doctors and physicians use these devices to treat patients and conduct blood tests blood after withdrawing it through intravenous route. These devices are also used for therapeutic reasons like central venous pressure readings, blood sampling, blood transfusions, administration of medication, etc. Moreover, these devices are also used for administering various drug classes like antipyretics, antibiotics, and analgesics.
The report provides company market share analysis to give a broader overview of the key players in the intravenous access devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the intravenous access devices market on a global and regional basis.
Various factors are driving the intravenous access devices market globally, such as technological advancements for designing new products, ever-increasing global population, and rising incidences of various diseases like tuberculosis, cancer, etc. In addition, rapid urbanization and changing lifestyle patterns also contribute to the global intravenous access devices market. Moreover, the rising number of hospitalizations also fuels the intravenous access devices market. However, the risks associated with using needles and moderate government regulations for intravenous insulin approvals may limit the intravenous access devices market. Nevertheless, the increasing patient population and rising disposable income of the people in developing countries are likely to offer ample market opportunities.
The study provides a decisive view of the intravenous access devices market by segmenting it based on product type, end-user, and region.
Based on product type, the market is divided into intravenous infusion pumps, intravenous catheters (midline peripheral and central catheters), and intravenous needles. Central catheters are sub-divided into centrally inserted and midline peripheral catheters. Intravenous infusion pumps are further classified into parenteral feeding infusion pumps, intravenous insulin infusion pumps, intravenous syringe infusion pumps, and intravenous patient controlled analgesia infusion pumps.
By end-user, the market is categorized into dialysis centers, hospitals, home care, clinics, and others.
The regional segmentation, includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Report Attributes | Report Details |
---|---|
Report Name | Intravenous Access Devices Market |
Market Size in 2023 | USD 6.08 Billion |
Market Forecast in 2032 | USD 12.36 Billion |
Growth Rate | CAGR of 8.2% |
Number of Pages | 110 |
Key Companies Covered | Becton, Dickinson & Company, Teleflex, B. Braun Melsungen, Medtronic, Hospira, Smiths Medical, Fresenius Medical Care, Covidien, Baxter International, CareFusion |
Segments Covered | By product type, By end-user and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America dominates the intravenous access devices market globally, due to the rising population. Additionally, the growing chronic disease incidences result in the establishment of more hospitals, which drives the demand for intravenous access devices for treating patients suffering from various diseases. Europe held the second spot in 2023 in the intravenous access devices market globally, due to the increasing regional awareness about intravenous access devices and its benefits. The Asia Pacific intravenous access devices market shall register the highest CAGR over the forecast time period, owing to the growing R&D activities, faster adaptability of technologically advanced treatments using intravenous access devices, increasing population, rising disposable income and healthcare expenditure.
Some major players operating in the global intravenous access devices market are
This report segments the global intravenous access devices market into:
Global Intravenous Access Devices Market: By Product
Global Intravenous Access Devices Market: By End-User
Global Intravenous Access Devices Market: By Region
FrequentlyAsked Questions
Intravenous access devices are a part of vascular access devices, which play a crucial role in the healthcare sector. These devices are inserted into a person’s veins through peripheral vessels for treating diagnostic conditions.
Various factors are driving the intravenous access devices market globally, such as technological advancements for designing new products, ever-increasing global population, and rising incidences of various diseases like tuberculosis, cancer, etc.
According to a study, the global intravenous access devices Industry size was $6.08 Billion in 2023 and is projected to reach $12.36 Billion by the end of 2032.
The global intravenous access devices market is expected to grow at a CAGR of 8.2% during the forecast period.
North America dominates the intravenous access devices market globally, due to the rising population.
Some major players operating in the global intravenous access devices market are Becton, Dickinson & Company, Teleflex, B. Braun Melsungen, Medtronic, Hospira, Smiths Medical, Fresenius Medical Care, Covidien, Baxter International, CareFusion.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed